Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer

Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer

NCT06478394 ·Status: RECRUITING

Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT)

NCT02686424 ·Status: SUSPENDED

Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis

NCT06109805 ·Status: COMPLETED

Exploring the Difference Between Gastric Cardia Cancer and Non-cardia Gastric Cancer Based on Multiomics

NCT05812287 ·Status: NOT_YET_RECRUITING

Biomarker Study of PDR001 in Combination With MCS110 in Gastric Cancer

NCT03694977 ·Status: UNKNOWN ·Phase: PHASE2

Gastric Cancer Registry for Epidemiology and Molecular Risk Factor

NCT03046745 ·Status: UNKNOWN

Study of Faecal Bacteria Detection in Early Screening and Diagnosis of GC

NCT04638959 ·Status: UNKNOWN

Study of ARQ 197 Monotherapy

NCT01152645 ·Status: COMPLETED ·Phase: PHASE2

Investigation of the Proportion of Human Epidermal Growth Factor Receptor 2 Protein Overexpression of Gastric Adenocarcinoma and Prognostic Effect of HER2, and Analysis of Practice Pattern of Herceptin Use in Stage IV Gastric Cancer

NCT02136836 ·Status: UNKNOWN

A Multi-omics-based Metabolic Typing Study of Gastric Cancer

NCT06134011 ·Status: ACTIVE_NOT_RECRUITING

Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer

NCT04850716 ·Status: UNKNOWN

Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.

NCT02233712 ·Status: COMPLETED ·Phase: PHASE2

A Validation Study of Relationships Among Genomic Gene Expression Profile, Prognosis and Prediction of Adjuvant Chemotherapy Benefit With Capecitabine and Oxaliplatin in Gastric Cancer Stage II and III (6th AJCC) Patients After D2 Surgery (CLASSIC)

NCT03403296 ·Status: COMPLETED

Diagnosis of Peritoneal Exfoliative Cytology-positive Gastric Cancer Based on Artificial Intelligence-driven Virtual Biopsy Technology

NCT06759467 ·Status: COMPLETED

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

NCT00526669 ·Status: COMPLETED ·Phase: PHASE2

A Multifactor Prediction Model for Non-curative Outcomes in Mixed-type Early Gastric Cancer

NCT07096947 ·Status: COMPLETED

A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas

NCT02215447 ·Status: UNKNOWN ·Phase: PHASE2

The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding

NCT02150447 ·Status: TERMINATED ·Phase: PHASE3

Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET

NCT05385861 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2

A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment

NCT02711969 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer

NCT05334719 ·Status: ACTIVE_NOT_RECRUITING

Antiangiogenic Factors in Gastric Cancer

NCT00735566 ·Status: COMPLETED

First-Line and Neoadjuvant Immunotherapy for Gastric Cancer

NCT06727981 ·Status: RECRUITING

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

NCT04022109 ·Status: RECRUITING

Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer

NCT05831488 ·Status: UNKNOWN